Position in NVS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$5,269,553
-$7,959 QoQ
Shares Held
33,624
-2.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.60%
of 13F equity value
Holder Rank
#255
of 1,603 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Greenfield Seitz Capital Management, LLC holds $12,882,900 across 5 Drug Manufacturers - General names. NVS ranks #2 (40.9% of the industry book) .
All Filings in NVS
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,269,553 | 33,624 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $5,277,512 | 34,550 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $4,808,216 | 34,875 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $4,546,492 | 35,453 | Shares | Sole | 2025-11-24 | |
| 2025-06-30 | $5,247,840 | 43,367 | Shares | Sole | 2025-11-24 | |
| 2025-03-31 | $4,841,241 | 43,427 | Shares | Sole | 2025-11-24 | |
| 2024-12-31 | $4,306,356 | 44,254 | Shares | Sole | 2025-11-24 | |
| 2024-09-30 | $5,019,702 | 43,642 | Shares | Sole | 2025-11-24 | |
| 2024-06-30 | $4,740,663 | 44,530 | Shares | Sole | 2025-11-24 | |
| 2024-03-31 | $4,312,416 | 44,582 | Shares | Sole | 2025-11-24 | |
| 2023-12-31 | $4,600,496 | 45,563 | Shares | Sole | 2025-11-24 | |
| No filing history on record for this holder in this stock. | ||||||